Les performances des tests de dépistage de la trisomie 21 fœtale par analyse de l’ADN libre circulant
- MeSH Terms
- Genetic Testing (E05.200.562); Genetic Testing (E05.393.435); Genetic Testing (N02.421.143.827.233.221); Genetic Testing (N02.421.308.430); Mass Screening (E01.370.500); Mass Screening (E05.318.308.250.580); Mass Screening (N02.421.143.827.233.443); Mass Screening (N02.421.726.233.443); Mass Screening (N05.715.360.300.375.500); Mass Screening (N06.850.520.308.250.580); Mass Screening (N06.850.780.500); Down Syndrome (C10.597.606.643.220); Down Syndrome (C16.131.077.327); Down Syndrome (C16.131.260.260); Down Syndrome (C16.320.180.260); Genetic Testing (E01.370.225.562)
- Publication Scope
- assessment
- counselling
- implementation
- management
- patient_education
- prevention
- prognosis
- rehabilitation
- screening
- treatment
- Countries of Application
- France
- Guideline Publication Status
- Published
- Languages
- French
- Authors
- HAS (FR)
- Publication Year
- 2015